A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants

Clinical trial NCT06532396 · COMPLETED

Trial details

NCT number: NCT06532396
Sponsor: QurAlis Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-07-01
Primary completion: 2024-12-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.